These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8695564)

  • 1. Systemic effects of screening for retinopathy of prematurity.
    Laws DE; Morton C; Weindling M; Clark D
    Br J Ophthalmol; 1996 May; 80(5):425-8. PubMed ID: 8695564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic manifestations in response to mydriasis and physical examination during screening for retinopathy of prematurity.
    Rush R; Rush S; Nicolau J; Chapman K; Naqvi M
    Retina; 2004 Apr; 24(2):242-5. PubMed ID: 15097885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency and safety of phenylephrine and tropicamide used in premature retinopathy: a prospective observational study.
    Alpay A; Canturk Ugurbas S; Aydemir C
    BMC Pediatr; 2019 Nov; 19(1):415. PubMed ID: 31690284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of phenylephrine 2.5% with cyclopentolate 0.5% for retinopathy of prematurity screening in 1246 eye examinations.
    Neffendorf JE; Mota PM; Xue K; Hildebrand GD
    Eur J Ophthalmol; 2015; 25(3):249-53. PubMed ID: 25449644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower stress responses after Newborn Individualized Developmental Care and Assessment Program care during eye screening examinations for retinopathy of prematurity: a randomized study.
    Kleberg A; Warren I; Norman E; Mörelius E; Berg AC; Mat-Ali E; Holm K; Fielder A; Nelson N; Hellström-Westas L
    Pediatrics; 2008 May; 121(5):e1267-78. PubMed ID: 18450869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal necrotising enterocolitis due to mydriatic eye drops.
    Ozgun U; Demet T; Ozge KA; Zafer D; Murat S; Mehmet Y; Nilgun K
    J Coll Physicians Surg Pak; 2014 May; 24 Suppl 2():S147-9. PubMed ID: 24906272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient paralytic ileus following the use of cyclopentolate-phenylephrine eye drops during screening for retinopathy of prematurity.
    Lim DL; Batilando M; Rajadurai VS
    J Paediatr Child Health; 2003; 39(4):318-20. PubMed ID: 12755944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of mydriatic eyedrops in low-weight infants.
    Isenberg S; Everett S; Parelhoff E
    Ophthalmology; 1984 Mar; 91(3):278-9. PubMed ID: 6546977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams.
    Mitchell A; Hall RW; Erickson SW; Yates C; Lowery S; Hendrickson H
    Curr Eye Res; 2016 Dec; 41(12):1601-1607. PubMed ID: 27159349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic adverse events after screening of retinopathy of prematurity with mydriatic.
    Obata S; Imamura T; Kakinoki M; Yanagi T; Maruo Y; Ohji M
    PLoS One; 2021; 16(9):e0256878. PubMed ID: 34499693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiopulmonary arrest following administration of Cyclomydril eyedrops for outpatient retinopathy of prematurity screening.
    Lee JM; Kodsi SR; Gaffar MA; Rubin SE
    J AAPOS; 2014 Apr; 18(2):183-4. PubMed ID: 24698618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying and qualifying the use of topical anesthetics in retinopathy of prematurity examinations.
    Ahmed M; Forcina B; Bonsall D
    J AAPOS; 2016 Apr; 20(2):177-8. PubMed ID: 26994502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient ileus associated with the use of mydriatics after screening for retinopathy of prematurity in a very low birth weight infant.
    Degirmencioglu H; Oncel MY; Calisici E; Say B; Uras N; Dilmen U
    J Pediatr Ophthalmol Strabismus; 2014 Jul; 51 Online():e44-7. PubMed ID: 25003832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of mydriatic eye drops on cerebral blood flow and oxygenation in retinopathy of prematurity examinations.
    Kara N; Arman D; Seymen Z; Eratlı G; Gül A; Cömert S
    Eur J Pediatr; 2023 Nov; 182(11):4939-4947. PubMed ID: 37606703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sweeten, soother and swaddle for retinopathy of prematurity screening: a randomised placebo controlled trial.
    O'Sullivan A; O'Connor M; Brosnahan D; McCreery K; Dempsey EM
    Arch Dis Child Fetal Neonatal Ed; 2010 Nov; 95(6):F419-22. PubMed ID: 20876596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute gastric dilatation complicating the use of mydriatics in a preterm newborn.
    Sarici SU; Yurdakök M; Unal S
    Pediatr Radiol; 2001 Aug; 31(8):581-3. PubMed ID: 11550771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for retinopathy of prematurity: is it painful?
    Belda S; Pallás CR; De la Cruz J; Tejada P
    Biol Neonate; 2004; 86(3):195-200. PubMed ID: 15240989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serious adverse side effects after pupillary dilation in preterm infants].
    Lux AL; Mouriaux F; Guillois B; Fedrizzi S; Peyro-Saint-Paul L; Denion E
    J Fr Ophtalmol; 2015 Mar; 38(3):193-8. PubMed ID: 25726252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pupil dilatation after single and triple doses of mydriatic agent in preterm infants.
    Punyawattanaporn A; Tengtrisorn S; Sangsupawanich P
    J Med Assoc Thai; 2009 Nov; 92(11):1458-62. PubMed ID: 19938737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of mydriatics in low-birth-weight infants.
    Isenberg S; Everett S
    J Pediatr; 1984 Jul; 105(1):111-2. PubMed ID: 6737125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.